BioStock: PHI on how TO 3 proceeds will be used
On May 2, the redemption period of Phase Holographic Imaging’s warrants of series TO 3 ends. The company can receive approximately SEK 12 million after issue costs if fully subscribed. Insiders such as the company’s founder and CEO and also the company’s largest shareholder, Altium, are among those who subscribed for new shares in PHI. BioStock talked to CEO Patrik Eschricht to learn how the proceeds would be used.
Read the full interview with Patrik Eschricht at biostock.se:
https://www.biostock.se/en/2023/04/phi-on-how-to-3-proceeds-will-be-used/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/
The content of the article is sponsored by the company in question that appears in the text. BioStock does not provide investment advice or mediate any investment orders. BioStock assumes no responsibility for actions and/or any loss or damage based on the use of content posted on BioStock.se. Instead, each investment decision is made independently by the individual investor.
